Antithrombotic Therapy for Venous Thromboembolic Disease

This publication has 197 references indexed in Scilit:

• Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism
  The Lancet, 1992
• The Antithrombotic Activity and Pharmacokinetics of Enoxaparine, A Low Molecular Weight Heparin, In Humans Given Single Subcutaneous Doses of 20 to 80 mg
  The Journal of Clinical Pharmacology, 1988
• Early reversal of right ventricular dysfunction in patients with acute pulmonary embolism after treatment with intravenous tissue plasminogen activator
  Journal of the American College of Cardiology, 1987
• HEPARIN DOSES AND MAJOR BLEEDINGS
  The Lancet, 1986
• Heparin and the In-Hospital Management of Deep Venous Thrombosis: Cost Considerations
  Mayo Clinic Proceedings, 1986
• Thromboembolism, Coumarin Necrosis, and Protein C
  Mayo Clinic Proceedings, 1985
• Intravenous urokinase in acute myocardial infarction
  The American Journal of Cardiology, 1985
• Is warfarin sodium contraindicated in the lactating mother?
  The Journal of Pediatrics, 1983
• Heparin therapy: A randomized prospective study
  American Heart Journal, 1979
• Arterial thromboembolic complications with aortic ball valve prostheses
  American Heart Journal, 1978